Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 850 of 1475 entries
View as:

Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00578916 Org: User:
Start: 01/31/08 End: 01/31/08 Due: 01/31/09

A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00724334 Org: User:
Start: 07/31/08 End: 05/31/14 Due: 05/31/15

An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02576509 Org: User:
Start: 12/07/15 End: 02/07/24 Due: 02/07/25

A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05638282 Org: User:
Start: 02/15/23 End: 06/27/23 Due: 06/27/24

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02869789 Org: User:
Start: 10/05/16 End: 05/13/22 Due: 05/13/23

PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02492815 Org: User:
Start: 10/31/13 End: 04/30/16 Due: 04/30/17

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163

Phase: N/A Priority: Normal
NCT ID: NCT01079819 Org: User:
Start: 04/30/10 End: 12/31/10 Due: 12/31/11

Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT02250001 Org: User:
Start: 09/30/14 End: 01/20/17 Due: 01/20/18

Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney

Phase: N/A Priority: Normal
NCT ID: NCT00035555 Org: User:
Start: 03/31/01 End: 07/31/12 Due: 07/31/13

A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00312754 Org: User:
Start: 06/30/05 End: 04/30/07 Due: 04/30/08

Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01478048 Org: User:
Start: 11/30/11 End: 04/21/17 Due: 04/21/18

A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05981976 Org: User:
Start: 08/18/23 End: 12/14/23 Due: 12/14/24

Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise

Phase: N/A Priority: Normal
NCT ID: NCT04472494 Org: User:
Start: 10/14/20 End: 09/13/21 Due: 09/13/22

Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01886599 Org: User:
Start: 11/30/12 End: 02/28/13 Due: 02/28/14

Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)

Phase: N/A Priority: Normal
NCT ID: NCT00116298 Org: User:
Start: 01/31/01 End: 01/31/05 Due: 01/31/06

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

Phase: N/A Priority: Normal
NCT ID: NCT03189069 Org: User:
Start: 10/06/16 End: 05/31/17 Due: 05/31/18

Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00410072 Org: User:
Start: 04/30/07 End: 10/31/10 Due: 10/31/11

A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00409838 Org: User:
Start: 04/30/07 End: 12/31/11 Due: 12/31/12

An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT03386838 Org: User:
Start: 03/28/18 End: 04/19/18 Due: 04/19/19

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)

Phase: N/A Priority: Normal
NCT ID: NCT02227459 Org: User:
Start: 10/31/14 End: 05/31/16 Due: 05/31/17

An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02409368 Org: User:
Start: 04/29/15 End: 08/27/21 Due: 08/27/22

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04908189 Org: User:
Start: 07/15/21 End: 11/12/26 Due: 11/12/27

A Study of the Alternative Administration of Ixabepilone and Vinflunine

Phase: N/A Priority: Normal
NCT ID: NCT00362830 Org: User:
Start: 08/31/06 End: 09/30/07 Due: 09/30/08

Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02843659 Org: User:
Start: 10/18/16 End: 07/24/17 Due: 07/24/18

Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT03004768 Org: User:
Start: 01/26/17 End: 02/27/17 Due: 02/27/18